Liraglutide may reduce BMI in youth with type 2 diabetes
This study evaluated the efficacy of liraglutide compared to placebo for weight loss in children and adolescents with type 2 diabetes, revealing some reduction in BMI metrics.
Research feed
Recently added diabetes research, organized by intervention and outcome.
Sorted by when Dediabetes added each study.
This study evaluated the efficacy of liraglutide compared to placebo for weight loss in children and adolescents with type 2 diabetes, revealing some reduction in BMI metrics.
The study investigated the effects of liraglutide on beta-cell function in individuals with well-controlled type 2 diabetes, finding a significant improvement in the disposition index.
Once-weekly exenatide significantly improved glycaemic control in adults with type 2 diabetes compared to placebo.
This study compared the effects of exenatide and insulin glargine on body composition in overweight and obese patients with type 2 diabetes. Exenatide significantly reduced body weight and fat mass, while glargine increased these measures.
This study analyzed the pharmacokinetics of insulin degludec/liraglutide in 720 Chinese individuals with type 2 diabetes over 26 weeks, revealing unclear effectiveness.
The GRADE study compared the effectiveness of four diabetes medications and found significant reductions in HbA1c levels and time to primary failure for all treatments.
Liraglutide treatment significantly reduced sST2 levels in obese patients with prediabetes or early T2DM, while lifestyle counseling had no significant effect.
This study evaluated the efficacy and safety of dulaglutide in patients with type 2 diabetes inadequately controlled with metformin, demonstrating significant reductions in HbA1c and body weight.
This study investigated the effects of GLP-1 receptor agonists and DPP-4 inhibitors on gallbladder volume and bile acid profiles in type 2 diabetes patients, finding significant changes in bile acid levels with liraglutide and sitagliptin.
This randomized controlled trial investigated the effects of incretin-based therapies on insulin clearance in type 2 diabetes. It found significant differences in insulin clearance between treatments.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.